Evidence map›Paper›PMID 28450990›Full record

ArticleThe Pan African medical journal2017

[Anatomopathological profile of breast cancer in cape bon, Tunisia].

Ghada Sahraoui, Fatma Khanchel, Emna Chelbi

Abstract read
In one paragraph

Article in The Pan African medical journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ghada SahraouiService d'Anatomie et Cytologie Pathologiques, Hôpital Mohamed Taher Mâamouri, Nabeul, Tunisie.
Fatma KhanchelService d'Anatomie et Cytologie Pathologiques, Hôpital Mohamed Taher Mâamouri, Nabeul, Tunisie.
Emna ChelbiService d'Anatomie et Cytologie Pathologiques, Hôpital Mohamed Taher Mâamouri, Nabeul, Tunisie.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common cancer among tunisian women and worldwide. In Cape Bon, Tunisia, the anatomopathological features of this cancer have not been established in previously published studies. Knowledge about these features is needed for the cultural adaptation of prevention and health care systems in the region. The aim of our study was to determine the pathological profile of breast cancers in the only public health anatomic pathology regional laboratory. We conducted a retrospective descriptive study of 116 patients who were diagnosed with breast cancers in our laboratory over a 5-year period, from July 2010 to July 2015. Our study included 116 patients. The average age was 51 years. The mean histologic tumor size was 31 mm. The initial diagnosis was based on lumpectomy in 83% of the cases. Nonspecific invasive cancer was the most frequent histological type. SBR grade III was most prevalent. Lymphovascular invasion was detected in 33% of cases. Axillary lymph node dissection was performed in 72% of cases. Hormone receptors were positive in 73% of cases. Her2-Neu receptors were overexpressed in 19% of cases. The ki67 was ≥ 14% in 38% of cases. Luminal A was the most common molecular subtype. In Cap Bon region brest cancer is characterized by an early onset, a large tumor size and pejorative histoprognostic factors.

Indexed as

AdultAgedAged, 80 and overBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesFemaleHumansKi-67 AntigenLymphatic MetastasisLymph Node ExcisionMastectomy, SegmentalMiddle AgedNeoplasm GradingNeoplasm InvasivenessRetrospective StudiesTunisiaERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesKi-67 AntigenBreast cancerhistopathologyTunisia

Identifiers

PMID28450990
PMCPMC5398263

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.